Incannex Healthcare Inc.
Financial highlights
| Metric | FY 06/30/25 | FY 06/30/24 | FY 06/30/23 | FY 06/30/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $86,000 | $12,000 | — | — |
| Research and development | $10.7M | $12.9M | $6.3M | — |
| Operating expenses | $23.9M | $30.1M | $49.7M | — |
| Operating income | -$23.8M | -$30.0M | -$49.7M | — |
| Interest expense | $303,000 | — | — | — |
| Pretax income | -$46.9M | -$18.4M | -$48.8M | — |
| Income tax expense | — | $30,000 | — | — |
| Net income | -$46.9M | -$18.5M | -$48.8M | — |
| Balance Sheet | ||||
| Cash and equivalents | $15.0M | $5.9M | $22.1M | — |
| Current assets | $20.0M | $16.2M | $23.0M | — |
| Total assets | $20.4M | $17.0M | $23.8M | — |
| Current liabilities | $7.0M | $5.6M | $2.5M | — |
| Total liabilities | $7.1M | $5.8M | $3.0M | — |
| Stockholders' equity | $13.4M | $11.2M | $20.8M | $24.7M |
| Cash Flow Statement | ||||
| Cash from operations | -$12.5M | -$15.8M | -$10.7M | — |
| Depreciation and amortization | $143.0B | $103.0B | $23.0M | — |
| Stock-based compensation | $2.6M | $8.9M | $2.1M | — |
| Capital expenditure | $8,000 | $277,000 | $316,000 | — |
| Free cash flow | -$12.5M | -$16.1M | -$11.1M | — |
Shares outstanding 12.0M · Free float 34.3%
Annual filing data through FY ended June 30, 2025; float as of July 16, 2026.